PCN230 REAL-WORLD RATES AND MANAGEMENT OF THROMBOCYTOPENIA DUE TO CANCER TREATMENT IN ADVANCED/METASTATIC FEMALE GENITOURINARY MALIGNANCIES von Ransom, J., Buderi, R., Galaznik, A., Rusli, E.

Volltext

PCN285 USE OF REAL-WORLD DATA AND MACHINE LEARNING TO REDUCE TREATMENT-LIMITING ADVERSE EVENTS IN AN ACUTE MYELOID LEUKEMIA CLINICAL TRIAL POPULATION von Buderi, R., Ransom, J., Galaznik, A., Berger, M.

Volltext

PND83 Treatment Patterns of Antihypertensive Medications Among Alzheimer's Disease Patients in United States and France von Wing, V., Buderi, R., Vigna, C., Rusli, E., Jain, R., Galaznik, A.

Volltext

PND81 Clinical and Demographic Factors Associated with Prescribing Disease Modifying Agents in Multiple Sclerosis Patients: A Real World Study Using French Electronic Medical Recor... von Vigna, C., Wing, V., Rusli, E., Buderi, R., Jain, R., Galaznik, A.

Volltext

PND92 Healthcare Resource Utilization Among Alzheimer's Disease Patients Using Antihypertensive Medication in United States and France von Wing, V.K., Buderi, R., Vigna, C., Rusli, E., Jain, R., Galaznik, A.

Volltext

PCV5 3C-HF PROGNOSTIC SCORE TO PREDICT WORSENING CARDIAC FUNCTION AMONG CONGESTIVE HEART FAILURE PATIENTS IN UNITED STATES AND EUROPE von Rusli, E., Buderi, R., Galaznik, A., Shilnikova, A., Ransom, J., Lempernesse, B., Berger, M.

Volltext

PCN428 SCALABLE PREDICTION OF CANCER PATIENT CLINICAL EVENTS IN REAL WORLD CLINICAL SETTINGS von Ransom, J., Galaznik, A., Buderi, R., McLean, C., Shilnikova, A., Lempernesse, B., Berger, M.

Volltext

EPH4 Validation of Novel Identification Algorithms for Nonfatal Myocardial Infarction Using Uniform Objective Criteria and Pooled Clinical Trial Data von Ports, K., Chen, W., Saunders, D., Koduru, B., Aptekar, J., Spanias, J., Strait, C., Tso, C., Buderi, R., Gerome, D., Bourlon, P.L., Saltzman, S., Jain, T., Talwai, A., Jain, R.

Volltext

Alaskan oil spill: survivors return to the wild von Buderi, R

Volltext

Berkeley's Changing Student Populaton: Academic successes by a growing Asian population are exerting pressure on current admissions policies, as well as creating a new kind of raci... von Buderi, R

Volltext

'Wellness Letter' tops subscription stakes von Buderi, Robert

Volltext

Cetus banks on interleukin von Buderi, Robert

Volltext

Row over controversial new AIDS drug von Buderl, Robert

Volltext

Funding Central Research von Buderi, Robert

Volltext

NEC-style dual ladder boosts lab productivity

Volltext

IBM scientists take on product responsibilities von Buderi, Robert

Volltext

Intel researchers aim to think big while staying close to development von Buderi, Robert

Volltext

Corporate Strategy: Spinoff To Market Technology From NEC Research Institute von Buderi, Robert

Volltext

Drug approval: product licensing by phone von Buderi, R

Volltext

How the earth moved...and the pollution didn't von Buderi, R

Volltext